dana foss retweeted
Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new omics-driven evidence and broadly rising drugability.
Nice explanation of the benefits of the emerging hub-and-spoke model in biotech!
nasdaq.com/articles/how-this…
We made the cover @natBME with our recent work from my postdoc @RossWilsonLab @igisci @UCBerkeley
Congrats to the whole team who contributed to this work!!!
The May cover illustrates that a peptide identified via screening aids the delivery of CRISPR ribonucleoprotein into cells, increasing the yield of edited primary human lymphocytes.
go.nature.com/43bqgeH
rdcu.be/dcxCM [Paper]
dana foss retweeted
Excited to highlight @natBME cover story on PERC, peptide-based delivery of #CRISPR RNPs into T cells for ex vivo gene editing with reduced toxicity vs. electroporation. Great work from @dv_foss et al. @RossWilsonLab @j_eyquem @MarsonLab #CARTcell rdcu.be/dcw3w
Thanks as always to the fantastic #scicomm team @igisci for this summary of our recent published work @RossWilsonLab , giving context and take-home impacts that are approachable for a general audience! Please check out this write up linked below.
This Post is from an account that no longer exists. Learn more
Very excited to share our report out @natBME which is the result of my postdoc work @RossWilsonLab @igisci @UCBerkeley. Very grateful to co-first authors David Nguyen from @MarsonLab and @JoeJMuldoon from @j_eyquem lab @UCSF, as well as the *whole team* who made it all possible!!
I’m excited to share our report - out now in @natBME - of a new approach to CRISPR delivery that is poised to transform the way engineered T cell therapies are manufactured. Visit tinyurl.com/CRISPR-PERC for “how to” details. It’s threadin’ time! (1/11) nature.com/articles/s41551-0…
dana foss retweeted
Great morning talk in the nonviral delivery session by @RossWilsonLab on “Peptide-enabled CRISPR enzyme delivery for immune cell engineering” 👏🏻🧫⚗️ #ASGCT22
dana foss retweeted
Donate to support the Ukrainian Red Cross and its work to help civilians in this difficult time for Ukraine! You can donate on
✅ URCS website: redcross.org.ua/donate/
✅ iRaiser platform:
donate.redcrossredcrescent.o…
📢 Please share!
#SupportUkraine #Ukraine #URCS #DonateUkraine
Bittersweet to announce I have finished my postdoc @RossWilsonLab and @igisci and am starting a new adventure @RelatedSciences!
It’s been such a special 4 years of RNP delivery & chocolate covered pretzels 🥨
Stay tuned for our upcoming preprint!
dana foss retweeted
Update: The CDC still recommends not asking graduate students how long they have left until they graduate.
dana foss retweeted
1. Major unlock of CRISPR potential empowered by metagenomics #NewMetaCRISPR. I’ve been hoping to see this happen for years: a way to edit the genomes of microorganisms within communities
dana foss retweeted
The Lareau Lab at Berkeley is looking to recruit a wet lab postdoc interested in mRNA translation and more. Check out our website for an overview of our research. lareaulab.org/
dana foss retweeted
Join me at UC Berkeley in a short-term position to work on identifying shared genomic variation in COVID breakthrough cases. Joint work with Kaiser Permanente, Berkeley SPH and the CDPH and funded by the Rockefeller foundation. tinyurl.com/2stjnyfw
dana foss retweeted
Planning my new fall curriculum. I'm pleased to announce a new online course that will teach people when to use "reply all" to respond to an e-mail message, and when just respond to the sender. Registration is open soon, so please sure to share. I know many people will benefit.
dana foss retweeted
If you’ve ever said “sorry this slide is so busy” I have massive news for you about who controls the content of your PowerPoint presentation
Excited to share this news of my colleagues starting a clinical trial aiming to cure sickle cell disease with CRISPR (all non-profit/academic backing) 👏👏 news.berkeley.edu/2021/03/30… via @ucberkeley
Kudos to my colleague @staciakwyman for all those bioinformatics skills making this effort a reality 💪💪
dana foss retweeted
Curious about therapeutic CRISPR delivery, and the potential of pre-formed RNP enzymes? Then I've got just the webinar for you! I review where we are and we're headed when it comes to non-viral delivery of editors like Cas9: youtu.be/_dOGxs2clJ0
